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Abstract
Rab37 belongs to a subclass of Rab GTPases regulating exocytosis, including also Rab3a and Rab27a. Proteomic studies
indicate that Rab37 is associated with insulin-containing large dense core granules of pancreatic b-cells. In agreement with
these observations, we detected Rab37 in extracts of b-cell lines and human pancreatic islets and confirmed by confocal
microscopy the localization of the GTPase on insulin-containing secretory granules. We found that, as is the case for Rab3a
and Rab27a, reduction of Rab37 levels by RNA interference leads to impairment in glucose-induced insulin secretion and to
a decrease in the number of granules in close apposition to the plasma membrane. Pull-down experiments revealed that,
despite similar functional effects, Rab37 does not interact with known Rab3a or Rab27a effectors and is likely to operate
through a different mechanism. Exposure of insulin-secreting cells to proinflammatory cytokines, fatty acids or oxidized low-
density lipoproteins, mimicking physiopathological conditions that favor the development of diabetes, resulted in a
decrease in Rab37 expression. Our data identify Rab37 as an additional component of the machinery governing exocytosis
of b-cells and suggest that impaired expression of this GTPase may contribute to defective insulin release in pre-diabetic
and diabetic conditions.
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Introduction
Diabetes mellitus is a metabolic disorder developing when the
organism becomes unable to maintain optimal blood glucose levels
[1]. Pancreatic b-cells play a fundamental role in this process.
Indeed, these cells are capable of sensing circulating levels of
glucose and other nutrients and to release insulin in a glucose-
responsive manner [2]. In b-cells, glucose metabolism leads to the
generation of ATP and to closure of ATP-sensitive K+-channels.
This causes membrane depolarisation and Ca2+ entry through
voltage-gated Ca2+-channels. The resulting increase in intracellu-
lar Ca2+ triggers insulin secretion [3]. Insulin exocytosis involves
the formation of protein complexes that regulate each step of the
secretory pathway, including docking, priming and fusion of
secretory granules. Among the components orchestrating hormone
release from pancreatic b-cells are the GTPases Rab3a and
Rab27a that play a central role in the late events of the secretory
pathway [4]. These GTPases have been found to interact with a
large set of effectors and to contribute to the control of docking
and fusion of insulin-containing granules. Rab37 has also been
reported to participate in regulated secretion in mammalian cells.
This GTPase displays high sequence homologies with Rab3a and
Rab27a and has been localized on secretory granules of
mastocytes [5] and Natural Killer cell secretory lysosomes [6].
Moreover, a proteomic study revealed that Rab37 is associated
with insulin-containing granules in the insulinoma cell line INS-1E
and in primary mice b-cells [7]. Despite these observations, the
potential involvement of this GTPase in the regulation of insulin
exocytosis from pancreatic b-cells has so far not been investigated.
In this study, we provide evidence that Rab37 is expressed in
human islets and b-cell lines and participates in the regulation of
insulin secretion. Moreover, we show that the expression of Rab37
is reduced under physiopathological conditions mimicking pre-




EGFP-tagged wild type Rab37, Rab3a and Rab27a and their
constitutively active mutants were generated as previously
described [8]. Mouse polyclonal Rab37 antibody was obtained
from Abcam (Cambridge, UK) while rabbit polyclonal Rab37
antibody was generated as described [8]. Mouse monoclonal anti-
GFP antibody was purchased from BD Transduction Laboratories
(San Jose, CA) while mouse anti-b-actin antibody was from Sigma
(Saint-Louis, MO).
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Silencing of Rab GTPases and ICER
Rab37 shRNAs (shRab37 (1), shRab37 (2)) and Rab3a shRNA
targeting the 19-nucleotide sequences: AGTGGTGACAGTG-
GATGGT, AGGGTGATCCGTTCTGAAG, and GGACAA-
CATTAATGTCAAG respectively, were subcloned into the ApaI
and EcoRI sites of the pSilencer1.0-U6 vector, enabling expression
of short hairpin RNAs under the control of the mouse U6
promoter [8]. The Rab27a shRNA was described elsewhere [9]. A
shRNA sequence directed against GFP (59-GACGUAAACGGC-
CACAAGUUC-39) was used as a negative control. For expression
studies in physiopathological conditions, we used a siRNA against
the repressor ICER (59-CTGGAGATGAAACTGCTGC-39 and
59-CTGGAGATGAAACTGATGA-39) [10,11].
Cell Culture and Transfections
The insulinoma cell lines MIN6B1 [12] and INS-1E [13,14]
were provided by Drs P. Halban (University of Geneva) and P.
Maechler (University of Geneva), respectively. MIN6B1 cells were
grown at 37uC and 5% CO2 in Dulbecco’s modified Eagle’s
medium (containing 15% fetal calf serum, 70 mM b-Mercapto-
ethanol, 50 units/ml penicillin, 50 mg/ml streptomycin) and INS-
1E cells in RPMI 1640 medium (containing 10% fetal calf serum,
70 mM b-Mercaptoethanol, 50 units/ml penicillin, 50 mg/ml
streptomycin and 0.1 mM sodium pyruvate). Transient transfec-
tions were performed using Lipofectamine 2000 (Invitrogen.
Carlsbad, CA). Transfection efficiency ranged between 30–50%.
To mimic physiopathological conditions favoring the development
of Type 1 or Type 2 diabetes, MIN6B1 cells were cultured for a)
24 h in the presence or absence of IL-1b alone (10ng/ml) or with a
combination of cytokines including TNFa (10 ng/ml), IFNc
(30 ng/ml) and IL-1b (0.1 ng/ml) b) 24 h, 48 h or 72 h with
0.5 mM palmitate complexed to BSA (1:5) c) 72 h with 2 mM
cholesterol of native LDL or mildly oxidized LDL (oxLDL).
Real-Time PCR Experiments
Total RNA was prepared using the Ambion’s RNA extraction
kit (Austin, TX). Reverse transcription reactions were performed
as previously described [15]. To assess shRab37 silencing
efficiency or Rab37 and Rab3a expression following chronic
exposure to either inflammatory cytokines, palmitate, native or
oxLDL, qRT-PCR assays were carried out on a BioRad MyIQ
Single-Color Real-Time PCR detection system using the BioRad
IQ SYBR Green Supermix, with initial primer concentrations of
6 mM and 16 ml of RT reaction per 64 ml of PCR and an
annealing temperature of 60uC. Primer sequences of Rab3a, Slp4/
granuphilin and Rplp0 are those previously published [16]. Primer
sequences for Rab37 were: sense, 59-
GTCTGCTTGGCTACCTCTGG-39; antisense, 59-GAACC-
CAGGTGGAAAGTTGA-39. Normalization of each qRT-PCR
reaction was performed by measuring 18S ribosomal RNA levels
with the following primers: sense, 59-GCCTTGACCTTTTCAG-
CAAG-39; antisense, 59-GGCCTCACTAAACCATCCAA-39.
Immunoblotting
For protein expression studies, insulinoma cell lines were placed
on ice, washed twice in phosphate-buffer saline and scraped in a
small volume of lysis buffer containing: 50 mM Tris-HCl, pH 7.5,
10% glycerol, 1% NP-40, 2.5 mM MgCl2, 80 mM KCl, 3 mM
CaCl2, 3 mM EDTA, 1 mM PMSF, 1 mg/ml leupeptin, 2 mg/ml
aprotinin, 10 mM NAF, 0.1 mM NaVO4 and 25 mM b-glycerol-
phosphate. The cells were sonicated and centrifuged for 5 minutes
at 12’0006g at 4uC. 50 mg of proteins were separated on SDS-
PAGE and transferred to PVDF membranes. The membranes
were incubated with specific antibodies and then with secondary
antibodies coupled to horseradish peroxidase. Bound antibodies
were visualized using an enhanced chemiluminescence detection
system (Amersham Biosciences).
Immunofluorescence
For immunocytochemistry, the cells were grown on polyor-
nithine/laminin-treated glass coverslips for 3 days. Cell monolay-
ers were rinsed twice with phosphate-buffered saline, fixed for
30 min in 4% paraformaldehyde and permeabilized for 10 min
with 0.1% Saponin. Following permeabilization, the coverslips
were treated with 5% BSA as a blocking solution and were then
incubated overnight at 4uC either with rabbit anti-Rab37, guinea
pig anti-insulin or mouse anti-Rab3a antibodies diluted in 5%
BSA and 0.1% Saponin. After rinsing with phosphate-buffered
saline, the cells were exposed to secondary antibodies coupled to
fluorescein isothiocyanate or rhodamine for 1 h at room
temperature. Coverslips were mounted on glass slides with
Fluorsafe, and analyzed by confocal microscopy (Leica SP5 AOBS
Confocal Microscope, Heidelberg, Germany).
hGH Release from MIN6B1 Cells
For secretion tests, the cells were co-transfected with the hGH-
encoding plasmid pXGH5 (24-well confluent dishes, 0.8 mg/well)
[17]. After 4 h of incubation at 37uC, the buffer was replaced with
fresh medium containing fetal calf serum, antibiotics and b-
Mercaptoethanol. Three days after the transfections, the culture
medium was replaced by KREBS-Ringer/bicarbonate-Hepes
buffer (KRBH, pH 7.4:127 mM NaCl, 4.7 mM KCl, 1.2 mM
KH2PO4, 1.2 mM MgSO4, 1 mM CaCl2, 5 mM NaHCO3,
25 mMHepes and 0.1% bovine serum albumin) containing 2 mM
glucose and the cells were incubated at 37uC for 30 min. The
preincubation buffer was then removed and the cells incubated in
KRBH containing either 2 mM glucose (basal condition) or
20 mM glucose (stimulatory condition). The amount of hGH
released into the medium and remaining in the cells under basal
and stimulating conditions was quantified by ELISA (Roche
Diagnostics, Rotkreuz, CH).
Interaction of the GTPases with Putative Effectors
The interaction of Rab GTPases with their effectors was
assessed by GST (Glutathione-S-Transferase)-pull down assays.
For this purpose, MIN6B1 cells grown in 6-well confluent dishes
were transfected with either pEGFP-C1 vector alone or with
EGFP-tagged Rab constructs (4 mg/well). Two days later, the
medium was removed and the cells washed with cold phosphate-
buffer saline. They were then scraped in pull-down buffer B
containing 20 mM Tris-HCl, pH 7.5, 200 mM NaCl, 10%
Glycerol, 1% Triton-X-100, 5 mg/ml Aprotinin and 5 mg/ml
Leupeptin. After 30 min on ice, cell lysates were centrifuged for
5 min at 4uC at 12’0006g. Lysates (500 mg) were loaded on
affinity columns consisting of Rab effector domains of Rim1,
Rim2, granuphilin/Slp4, Noc2, rabphilin or Slac2c/MyRIP
bound to glutathion agarose beads. After 60 min at 4uC, the
beads were washed three times and mixed with Laemmli buffer. At
the end of the pull-down assay, the proteins retained on the affinity
columns were recovered and analyzed by Western blotting.
Total Internal Reflection Fluorescence Microscopy
For total internal reflection fluorescence (TIRF) microscopy
experiments, a Zeiss Axiovert 200 inverted fluorescence micro-
scope was modified to allow epifluorescence and evanescence field.
For TIRF illuminations, the expanded beam (488 nm-568 nm
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argon krypton multi-line laser, 20 mW) was passed through an
AOTF wavelength selector synchronized with a SNAP-HQ CCD
Camera under Metafluor software control and introduced from
the high numerical aperture objective lens (100 X, 1.45 NA, Zeiss,
Germany). Light entering the coverslip underwent total internal
reflection at the glass-cell interface (penetration depth, 90 nm). For
our TIRF experiments, MIN6B1 cells were plated on glass
coverslips coated with 2 mg/ml poly-L-lysine and 33.2 mg/ml
laminin, and co-transfected either with shGFP or shRab37(2) and
with NPY-mRFP. As a positive control, MIN6B1 cells were
transfected with NPY-mRFP and plasmids encoding shRab3a or
shRab27a. Two days later, NPY-mRFP-positive docked granules
were imaged under 568 nm-TIRF illuminations. The cells were
incubated under resting conditions, and maintained at 37uC
Figure 1. Rab37 GTPase is expressed in b-cells and is localized on insulin-containing granules. A. Rab37 expression in insulinoma cell
lines (in bTC3, MIN6B1 and INS-1E cells), rat cortex and human pancreatic islets. Total lysates were immunoblotted with an anti-mouse Rab37
polyclonal antibody (detected band at 25 kDa). Protein loading was verified with an anti-mouse actin monoclonal antibody. B. Insulinoma cell lines
MIN6B1 (upper panel) and INS-1E (lower panel) were stained for Rab37 (a,d) and either insulin (b) or the GTPase Rab3a (d). After
immunocytochemistry, the cells were observed on a confocal microscope for colocalization (c,f). Insets represent higher magnifications of the boxed
regions. C. MIN6B1 (upper panel) and INS-1E (lower panel) cells were co-transfected with Rab37wt-EGFP (a,d) and with NPY-mRFP (b,e). Two days
later, the cells were fixed and observed on a confocal microscope. Rab37wt-EGFP co-localizes with NPY-containing large dense core granules (c,f).
Insets represent higher magnifications of the boxed regions.
doi:10.1371/journal.pone.0068255.g001
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during the whole experiment. For docking analysis, single NPY-
mRFP-positive granules were counted manually and single cell
area corresponding to docking surfaces (larger than 50 mm2)
measured. To observe exocytosis of NPY-mRFP at the single-
vesicle level, we used 568 nm-TIRF illumination as described
[18]. Single fusion events from NPY-mRFP granules were visually
recognized and counted manually. Images were acquired every
200 ms.
Statistical Analysis
Generally data from 3–7 independent experiments were
averaged. Error bars represent the standard error of the mean
(SEM) or, when indicated, standard deviations (SD). The
experiments were analyzed using the SAS statistical package
(SAS Inc., Cary NC, USA). For multiple comparisons, variance
analysis (ANOVA) was followed by the Bonferroni multiple
comparisons post-hoc test with a significance limit set at p,0.05
(p,0.01, or p,0.001).
Results
Rab37 is Expressed in b-cells and Colocalizes with Dense-
core Insulin-containing Granules
We first investigated the expression and subcellular localization
of Rab37 in pancreatic b-cells. Western blotting analysis showed
that the GTPase is expressed in several insulin-secreting cell lines,
including bTC3, INS-1E and MIN6B1, and is particularly
abundant in human islets (Fig. 1A). In contrast, in agreement
with previously published data [5], Rab37 was not detectable in
extracts of rat cortex. A proteomic study revealed that Rab37 is
associated with insulin-containing granules of INS-1E cells [7].
Indeed, analysis of INS-1E and MIN6B1 cells by immunolabeling
demonstrated a colocalization of Rab37 with Rab3a (Fig. 1B) and
Rab27a (Fig. S1), two GTPases associated with insulin-containing
granules [19]. Moreover, a fluorescently labelled construct
encoding wild-type Rab37 fused to EGFP (Rab37wt-EGFP)
transfected in INS-1E or MIN6B1 cells colocalized with fluores-
cently labelled Neuropeptide Y (NPY-mRFP), which is specifically
targeted to large-dense core vesicles (LDCVs) [20] (Fig. 1C).
Taken together these observations confirm the expression of
Rab37 in b-cells and its association with insulin-containing
granules.
Impact of Rab37 Knock-down on Glucose-induced
Secretion
To investigate the functional role of Rab37 in pancreatic b-cells,
we generated two shRNAs directed against Rab37 (shRab37 (1),
shRab37 (2)). The efficiency of these constructs in decreasing
Rab37 expression was assessed in MIN6B1 cells three days after
transfection. Transfection efficiency under our experimental
conditions was estimated to be about 40%. As shown in Fig. S2
transfection of shRab37 (1) and (2) reduced the level of the Rab37
transcript by 50% and 65%, respectively, and decreased the
expression of the protein by more than 50% (Fig. 2A, top panel).
Moreover, the shRNAs strongly diminished the expression of a co-
transfected EGFP-tagged Rab37 construct (Fig. 2A, bottom
panel). The specificity of the shRNAs was tested by analysing
their impact on the expression Rab3a and Rab27a, two closely
related GTPases. The results obtained show that shRab37
plasmids are not affecting the level of exogenously or endoge-
nously expressed Rab3a and Rab27a (Fig. S3).
Rab GTPases are important regulators of hormone and
neurotransmitter release. In pancreatic b-cells, Rab3a and Rab27a
play key roles in the process of insulin secretion [4]. Indeed,
Figure 2. Rab37 knock-down impairs hormone secretion induced by secretagogues. A. The level of endogenous Rab37 (upper panel)
and exogenously expressed Rab37-EGFP (lower panel) were estimated by immunoblotting in cells transfected with control shRNA, shRab37 (1) or
(2). Equal loading of the lanes was verified using an antibody against actin. B. To assess hormone release, the cells were transiently co-transfected
with a plasmid encoding the human growth hormone and with plasmids driving the expression of shRNAs against GFP (control) or with two different
shRNAs against Rab37 (shRab37 (1) or (2)). Three days later, the cells were tested for hormone release. For this, they were maintained at 2 mM
glucose, (open bars) and then incubated in stimulating solutions (filled bars) containing 20 mM glucose and the cAMP-raising agents Forskolin and
IBMX. The amount of hGH expressed by the cells and released in the medium was quantified by ELISA. Hormone secretion under basal and
stimulatory conditions is given as % of hGH cellular content. The results are the means of five independent experiments 6 SEM. ** p,0.01, ***
p,0.001. One-way ANOVA.
doi:10.1371/journal.pone.0068255.g002
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animals lacking either Rab3a or Rab27a are glucose intolerant
and display severe insulin exocytosis defects [19,21]. Rab37 is both
structurally and evolutionarily related to these two regulatory
GTPases. However, so far no information is available about a
possible involvement of Rab37 in the control of insulin exocytosis.
To investigate the function of Rab37 in b-cells we studied
hormone secretion in cells in which the endogenous level of the
GTPase is reduced by RNA interference. MIN6B1 cells were co-
transfected with plasmids encoding shRNAs against either GFP
(control) or Rab37 (shRab37 (1), shRab37 (2)) and with a plasmid
encoding the human Growth Hormone (hGH). When expressed in
b-cells, hGH is targeted to secretory granules and is co-released
with insulin [22]. Therefore, hGH secretion can be used to
selectively monitor the secretory process in cells expressing the
shRNAs. Three days after transfection, the cells were incubated at
resting glucose concentrations (2 mM glucose) or under stimula-
tory conditions (glucose 20 mM, Forskolin 10 mM and IBMX
0.1 mM) (Fig. 2B). Hormone secretion at 2 mM glucose was
similar in control and shRab37 transfected cells. In contrast,
hormone release elicited by 20 mM glucose and cAMP-raising
agents was reduced by 20% and 30%, (p,0.01) in cells expressing
the shRab37 (1) and (2), respectively. Together, these observations
suggest that Rab37 is required to maintain optimal secretory
functions in pancreatic b-cells.
Rab37 Knock-down Affects Docking and Exocytosis of
Insulin-containing Granules
The Rab GTPases Rab3a and Rab27a are critical regulators of
docking as well as exocytosis of secretory vesicles in neurons and
endocrine cells [8]. In b-cells, Rab3a and Rab27a regulate the last
steps of insulin secretion and control the docking/tethering event
[21,23]. In view of the impact of Rab37 knock-down on hormone
secretion we tested the role of the GTPase in insulin granule
docking and exocytosis. For this purpose, MIN6B1 cells were
analyzed by TIRF microscopy, which permits to selectively
visualize fluorescently-labelled vesicles located in close proximity
to the plasma membrane (less than 90 nm). The granules in close
apposition to the plasma membrane were counted in MIN6B1
cells transfected with shRab37 (2), which reduced more efficiently
glucose-stimulated hormone secretion, and its effect was compared
with shRNAs against GFP, Rab3a or Rab27a. The granules were
visualized by co-transfecting the cargo protein NPY-mRFP. Our
results show that shRab37 significantly affects docking of secretory
granules and reduced by more than 20% the number of secretory
vesicles localized close to the plasma membrane (Fig. 3A,B).
Interestingly, the impact of Rab37 silencing was comparable to the
effect obtained in cells expressing either shRab3a or shRab27a,
two constructs that have previously been reported to reduce
granule docking in PC12 cells [8]. Expression of either shRab3a or
Figure 3. Rab37 participates in docking of insulin-containing granules. A. Representative TIRF images showing docked NPY-mRFP
containing granules in MIN6B1 cells transfected either with control shGFP, shRBa3a, shRab27a or with shRab37 (2). B. Analysis of the docked granules
detected by TIRF illumination in the experiments shown in A. Histograms show the quantification of the number of docked granules per surface
(mm2). Results are means 6 SEM (shGFP, n = 41 cells; shRab37 (2), n = 38 cells; shRab3a, n = 33 cells; shRab27, n = 37 cells). * p,0.05 one-way ANOVA
test. C. Quantification of the exocytotic events from NPY-mRFP transfected MIN6B1 cells expressing control shGFP, shRab3a or shRab37 (2).
Exocytosis was triggered when indicated (Stimulation) by treating the cells with glucose, Forskolin and IBMX. Histograms represent the number of
fusion events counted every 60 s (n = 12). The results shown are the means 6 SEM. p * ,0.05 unpaired t-test.
doi:10.1371/journal.pone.0068255.g003
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shRab27a diminished the number of plasma-membrane-docked
vesicles by 36% and 22% respectively (Fig. 3A, B). These findings
are unlikely to be attributable to differences in cellular NPY-mRFP
expression because the levels of the granule marker (measured as
TotalNPY-mRFP Fluorescence/Areacell) in the cells transfected with
shRNAs against Rab3a, Rab27a and Rab37 selected for analysis
did not vary significantly.
We also explored the effect of shRab37 and shRab3a on
stimulus-evoked exocytosis of insulin-containing granules. In
shGFP-transfected MIN6B1 cells stimulation with a combination
of secretagogues including glucose (20 mM), KCl (30 mM),
Forskolin (10 mM) and IBMX (100 nM) induced an immediate
increased in the frequency of exocytic events of NPY-mRFP dense
core granules (,7 fold of the basal rate in the first 120 s after the
beginning of the stimulus, Fig. 3C). Transfection of either
shRab3a or shRab37 (2) decreased significantly the frequency of
the fusion events (253% and280%, respectively, in the first 120 s
following the stimulation; Fig. 3D, E, n = 24 cells, p.0.05).
Rab37 does not Interact with Rab3a and Rab27a Effector
Proteins
Rab3 and Rab27 bind to a variety of downstream effectors
[9,19,21,22,23]. To test a possible interaction of Rab37 with
Rab3a and/or Rab27a downstream effectors, we performed
in vitro GST-Pull down experiments. In agreement with previously
published data [24], Rab3a and Rab27a were both able to interact
with Noc2, granuphilin and Rabphilin (Fig. 4). In addition,
Rab3a interacted with Rim1 and 2, whereas Rab27a associated
with Slac-2/MyRIP. However, none of the tested effectors was
able to interact with Rab37 (Fig. 4). We have previously shown
that Calmodulin (Ca2+/CAM) can bind to Rab3a in a Ca2+-
dependent manner [25] through a specific domain of the GTPase
(Lys62-Arg85) including the basic amino acids Arg66-Arg70.
Alignments of the Ca2+/CAM-Rab3a-interacting sequence Lys62-
Arg85 with the corresponding amino acids of three other members
of the Rab GTPases family (Rab27a, Rab37 and Rab1a) shows
that the arginine at position 66 that is essential for Ca2+/CAM
binding is not conserved in Rab37, rendering very unlikely the
possibility of an interaction with this Rab3-specific effector (Fig.
S4).
Rab37 Expression in Physiopathological Conditions
We have previously shown that the expression of Rab3a,
Rab27a and Slp4/granuphilin is altered upon exposure of b-cells
to conditions mimicking those encountered in Type 2 diabetes
[16,26]. To assess whether Rab37 expression is also affected under
conditions leading to b-cell failure, MIN6B1 cells were chronically
exposed to proinflammatory cytokines, palmitate or oxidized Low-
density Lipoproteins (oxLDL). As shown in Fig. 5A, Rab37
mRNA levels are reduced to the same extent as Rab3a after
treatment of insulin-secreting cells with a mixture of proinflam-
matory cytokines including IL-1b, TNFa, and IFNc or with high
doses of IL-1b alone. Moreover, chronic exposure to either
palmitate (0.5 mM) (Fig. 5B) or oxLDL (2 mM) (Fig. 5C)
reduced mRNA levels of both Rab37 and Rab3a. We previously
reported that the decrease in Rab3a and granuphilin expression
observed in the presence of oxLDL or palmitate is due to
activation of the Inducible cAMP Element Repressor (ICER)
[11,16]. We found that this transcriptional repressor is also
involved in the reduction of Rab37. Indeed, silencing of ICER was
able to partially restore the level of Rab37 mRNA in MIN6B1
cells chronically exposed to palmitate or oxLDL (Fig. 5D–E).
Discussion
Pancreatic b-cells possess a sophisticated secretory machinery
allowing them to maintain optimal insulin exocytosis. Fine-tuning
of insulin release relies on the formation of SNARE complexes, the
activation of Ca2+-binding proteins and on the function of several
GTPases including the members of the Rab3 and Rab27 families
[27]. Indeed, these GTPases are important components regulating
the final events of insulin exocytosis, such as granule docking [28]
and functional defects involving them could play a role in the
development of metabolic diseases such as diabetes [27]. Recently,
proteomic studies have shown that Rab37, another GTPase
closely related to Rab3a and Rab27a, is highly enriched in b-cell
lines and mouse pancreatic islets [7,29]. In contrast, this GTPase is
not detectable in neuroendocrine cell lines such as PC12 [8].
Rab37 has been suggested to participate in the control of
exocytosis from mast cells [5]. However, no information was
available on the function of this GTPase in endocrine cells. Here
we confirm that Rab37 is expressed in insulin-secreting cells and
human pancreatic islets and demonstrate that the GTPase co-
localizes with Rab3a on insulin-containing granules. Moreover,
taking advantage of an RNA interference strategy, we could
demonstrate that Rab37 is involved in the process of insulin
exocytosis elicited by post-prandial glucose concentrations. As is
the case for Rab3a and Rab27a, Rab37 appears to be involved in
Figure 4. Rab37 does not interact with Rab3a and Rab27a
effectors. MIN6B1 cells were transfected either with pEGFP-C1 empty
vector or with the constitutively active mutants of different Rabs
(Rab3a, Rab27a or Rab37). GST-fusion proteins of different potential
downstream effectors (Rim1, Rim2, Noc2, granuphilin, rabphilin and
Slac-2/MyRIP) were immobilized on glutathion-agarose beads. Five
hundred micrograms of transfected MIN6B1 cell lysates were loaded on
the gluthation-agarose beads. pEGFP-labelled Rabs remaining attached
to the affinity columns were detected with an anti-GFP antibody (top
panel: INPUT, 50 mg proteins, anti-GFP; lower panels: GST-Pull down,
anti-GFP). Granuphilin, rabphilin and Noc2 interacted with both Rab27a
and Rab3a, whereas Rim1 and Rim2 bound only to Rab3a and MyRIP to
Rab27a. None of the downstream effectors tested interacted with
Rab37.
doi:10.1371/journal.pone.0068255.g004
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the final steps of the secretory pathway. In fact, silencing of this
GTPase resulted in a decrease in the number of granules in close
apposition to the plasma membrane and in the number of
exocytotic events in response to secretagogues, suggesting impair-
ment in the docking and fusion processes. These observations do
not exclude a contribution of Rab37 in other steps of the secretory
process such as transport of insulin-containing granules that will
need to be investigated in future experiments with specific
technical approaches.
In view of the sequence similarities between Rab37, Rab3a and
Rab27a and the analogous impacts on insulin secretion it was
reasonable to expect the interaction of Rab37 with at least some of
the well characterized downstream effectors of Rab3a and/or
Rab27a. However, GST-pull down experiments revealed that
Rab37 is unable to bind to known effector proteins. Thus, the
Figure 5. Effect of prolonged exposure to physiopathological conditions on Rab37 expression. Rab37 and Rab3a mRNA levels in MIN6B1
cells exposed for 24h to inflammatory cytokines (IL-1b alone or a mix of IL-1b TNFa, and IFNc) (A), to palmitate (0.5 mM, Palm) (B) or for 72 h to 2 mM
native or mildly oxidized LDL (oxLDL) (C) were quantified by qRT-PCR. MIN6B1 cells were transfected with control siRNA (siGFP, open bars) or siICER
(filled bars) and cultured with either BSA or 0.5 mM palmitate for 48 h (D) or with vehicle, 2 mM native or mildly oxidized LDL for 72 h (E). The mRNA
levels of Rab37 and granuphilin/Slp4 were quantified by qRT-PCR. The mRNA levels were normalized either against 18S (A–C) or against the
housekeeping gene acidic ribosomal phosphoprotein P0 (Rplp0) (D–E). The expression levels in control cells were set to 100%. Data are means of 6
SEM of at least 3 independent experiments (* p,0.05; ** p,0.01, one-way ANOVA).
doi:10.1371/journal.pone.0068255.g005
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mode of action of Rab37 appears to be distinct from that of the
other GTPases controlling docking and fusion of insulin-contain-
ing granules. At present, we don’t know whether Rab37 and the
other Rab GTPases associated with insulin-containing granules
play redundant roles, act sequentially or regulate the fate of
different granule pools [30,31]. Images taken by confocal
microscopy did not reveal major differences in the subcellular
localization of Rab37 and Rab3a. However, a detailed analysis of
the spatial distribution and the activation state of the different Rab
GTPases associated with insulin-containing secretory granules will
need to be carried out to definitively address this point.
Interestingly, we found that the expression of Rab37 is strongly
reduced following exposure of insulin-secreting cells to proin-
flammatory cytokines, palmitate or oxLDL particles. These
conditions have been reported to cause b-cell dysfunction
[32,33] and are believed to mimic physiopathological conditions
that favor the development of diabetes. Our data indicate that the
decrease in Rab37 expression is at least in part mediated by ICER,
a transcriptional repressor that is believed to contribute to b-cell
failure evoked by chronic hyperglycemia, hyperlipidemia and
oxLDL [11,16,34]. We have previously shown that induction of
ICER leads to reduced insulin expression and diminishes
transcription of the genes encoding Rab3a, Rab27a and their
effectors Slp4/granuphilin and Noc2 [11,16]. Thus, activation of
ICER may permit to achieve a coordinated shut down of a set of
genes involved in exocytosis. This will attenuate hormone
secretion under conditions of prolonged stimulation of b-cells
potentially contributing to the release of insufficient insulin to
cover the organism needs and to the development of diabetes.
In summary, the data obtained in the present study point to
Rab37 as a novel component participating in the cascade of events
controlling insulin exocytosis. The expression of this Rab GTPase
is strongly impaired under conditions resulting in b-cell dysfunc-
tion. Future studies in animal models will help clarifying whether
diminished expression of Rab37 contributes to defective insulin
secretion in pre-diabetic and diabetic conditions.
Supporting Information
Figure S1 Rab37 GTPase co-localizes with Rab27a-
containing granules. Confocal images showing a MIN6B1 cell
where endogenous Rab37 (red staining) co-localizes with endog-
enous Rab27a (green staining). Right images represent higher
magnifications of the boxed regions.
(PDF)
Figure S2 Efficiency of Rab37 silencing by RNA inter-
ference. The silencing efficiency of Rab37 was tested by
transfecting MIN6B1 cells either with a control shRNA (shGFP)
or with two different shRNAs against the GTPase (shRab37 (1) or
(2)). Three days following the transfection, total RNAs were
extracted in each condition. Rab37 mRNA levels were measured
by quantitative Real time-PCR. The results represent the means of
four independent experiments 6 SEM.
(PDF)
Figure S3 Efficiency of shRab37 on exogenous and
endogenous Rab3a and Rab27a. The impact of shRab37
on exogenously expressed Rab3a and Rab27a (A) and on the
endogenous level of these GTPases in PC12 cells (B) was studied
by immunoblotting using anti-Rab3A mouse monoclonal antibody
(dilution, 1:250) and anti-Rab27A mouse monoclonal antibody
(1:1000 dilution). Equal protein loading of the lanes was verified
using an antibody against actin. The positions of the molecular
weight markers are shown on the left.
(PDF)
Figure S4 The effector domain of Rab37 does not
contain the two arginines required for Ca2+/calmodulin
binding. Alignments of the Ca2+/CAM-Rab3a-interacting
amino acid sequence (Lys62-Arg85) including two positively
charged amino acids (Arg66-Arg70) with the analogous sequences
of Rab27a, Rab37 and Rab1a. As is the case for Rab27 and
Rab1a, Arg66 is not conserved in Rab37 rendering an interaction
of this GTPase with Ca2+/CAM very unlikely.
(PDF)
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